NeoDesign: a computational tool for optimal selection of polyvalent neoantigen combinations

Area of Science:

• Computational biology
• Vaccine development
• Immunotherapy

Background:

• Tumor polyvalent neoantigen mRNA vaccines are crucial for immunotherapy.
• Optimizing vaccine sequence design is essential for immunogenicity and safety.
• Selecting optimal sequences from large peptide and codon pools presents a significant challenge.

Purpose of the Study:

• To introduce NeoDesign, a computational tool for designing optimal sequences for tumor polyvalent neoantigen mRNA vaccines.
• To address the challenge of selecting optimal sequences from extensive combinations.
• To improve vaccine immunogenicity and safety through precise sequence design.

Main Methods:

• NeoDesign utilizes four modules: Library Construction, Optimal Path Filtering, Linker Addition, and λ-Evaluation.
• The tool identifies optimal protein sequences by minimizing linkers and avoiding unwanted neoantigens or functional domains.
• It incorporates a preference scheme to balance mRNA stability and protein expression.

Main Results:

• NeoDesign successfully identifies optimal protein sequences for polyvalent neoantigen vaccines.
• The tool simplifies vaccine structure and minimizes linker usage.
• It balances mRNA stability and protein expression for improved vaccine design.

Conclusions:

• NeoDesign offers a significant advancement in the sequence design of tumor polyvalent neoantigen mRNA vaccines.
• This computational tool has the potential to substantially improve immunotherapy strategies.
• NeoDesign facilitates the development of more effective and safer cancer vaccines.